SiameseParrot,
I take your point and agree - it's very misleading to talk cash cost when you're excluding, for example:
Royalties,
Depreciation / Amortization,
Corporate and Administrative costs,
Financing costs....
It's useful to know they aren't becoming more efficient out in the field (which is what cash will tell you), but it hides the true state of the union, which is worse IMO..
Wasn't there was a new standard coming out where the industry was going to move away from cash cost to an all-in?
- Forums
- ASX - By Stock
- KCN
- smashed
smashed, page-27
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KCN (ASX) to my watchlist
|
|||||
Last
$1.65 |
Change
0.000(0.00%) |
Mkt cap ! $425.2M |
Open | High | Low | Value | Volume |
$1.64 | $1.71 | $1.64 | $699.1K | 421.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 11106 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.67 | 1492 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 1.650 |
1 | 5000 | 1.645 |
1 | 1790 | 1.640 |
2 | 21790 | 1.635 |
2 | 16790 | 1.630 |
Price($) | Vol. | No. |
---|---|---|
1.665 | 1492 | 1 |
1.670 | 1492 | 1 |
1.675 | 1492 | 1 |
1.680 | 13133 | 2 |
1.685 | 1492 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
KCN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online